p38 MAPK SIGNAL PATHWAY INVOLVED IN ANTI-INFLAMMATORY EFFECT OF CHAIHU-SHUGAN-SAN AND SHEN-LING-BAI-ZHU-SAN ON HEPATOCYTE IN NON-ALCOHOLIC STEATOHEPATITIS RATS

African Journal of Traditional, Complementary and Alternative Medicines

Volumn 11, Issue 1, 2014, Pages 213-221

  Yang, Qinhe ^a   Xu, Yongjian ^a   Feng, Gaofei ^a   Hu, Chaofeng ^a   Zhang, Yupei ^a   Cheng, Shaobing ^a   Wang, Yanping ^a   Gong, Xiangwen ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

Hepatocytes; Non alcoholic Steatohepatitis; p38 mitogen activated protein kinase; Toll like receptor 4; Traditional Chinese medicine

Indexed keywords

ANTIINFLAMMATORY AGENT; CHAIHU SHUGAN SAN; CHAIHU-SHUGAN-SAN; HERBACEOUS AGENT; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PLANT EXTRACT; SHEN LING BAI ZHU; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANGIOSPERM; ANIMAL; ARTICLE; BLOOD; CHAIHU-SHUGAN-SAN (CSS); CHINESE MEDICINE; DRUG EFFECT; FATTY LIVER; LIPID DIET; LIPID METABOLISM; LIVER; LIVER CELL; MALE; METABOLISM; NONALCOHOLIC FATTY LIVER; P38 MITOGEN-ACTIVATED PROTEIN KINASE; PHOSPHORYLATION; PHYTOTHERAPY; RANDOMIZATION; RAT; SHEN-LING-BAI-ZHU-SAN (SLBZS); SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

CHAIHU-SHUGAN-SAN (CSS); HEPATOCYTES; NON-ALCOHOLIC STEATOHEPATITIS; P38 MITOGEN-ACTIVATED PROTEIN KINASE; SHEN-LING-BAI-ZHU-SAN (SLBZS); TOLL LIKE RECEPTOR 4; TRADITIONAL CHINESE MEDICINE;

ANGIOSPERMS; ANIMALS; ANTI-INFLAMMATORY AGENTS; DIET, HIGH-FAT; DRUGS, CHINESE HERBAL; FATTY LIVER; HEPATOCYTES; INTERLEUKIN-6; LIPID METABOLISM; LIVER; MALE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PHYTOTHERAPY; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84908878847     PISSN: None     EISSN: 25050044     Source Type: Journal    
DOI: 10.4314/ajtcam.v11i1.34     Document Type: Article

References (42)

1. Alisi, A., Panera, N., and Nobili, V. (2010). Toll-like receptor 4: A starting point for proinflammatory signals in fatty liver disease. Hepatology, 51: 714-715.
2. Angulo, P. (2002). Nonalcoholic fatty liver disease. N EngI J. Med. 346:1221-1231.
3. Chen, L., Zhu, J. S., and Ren, J. P. (2004). Protective and curative effects of Chaihu Shugan San (CHSGS) on acute liver injury caused by carbon tetrachloride in rats. Chin J. Integr. Med. Liver Dis., 14: 42-43.
4. Chiang, L. C., Ng, L. T., Liu, L. T., Shieh, D. E., and Lin, C. C. (2003). Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species. Planta Med., 69: 705-709.
5. Choi, S., Diehl, and A. M. (2005). Role of inflammation in nonalcoholic steatohepatitis. Curr. Opin. Gastroenterol., 21: 702-707.
6. Cohen, J. C., Horton, J. D., and Hobbs, H. H. (2011). Human fatty liver disease: Old questions and new insights. Science, 332: 1519-1523.
7. Day, C. P., and James, O. F. (1998). Steatohepatitis: A tale of two “hits”?. Gastroenterology, 114: 842–845.
8. Fu, D. C., Yang, S. Z., Song, X. F., and Xiao, Y. (2007). Effect of Chaihu Shugan San in treating liver fibrosis. Chin J. Gerontol., 27: 1146-1148.1. Alisi, A., Panera, N., and Nobili, V. (2010). Toll-like receptor 4: A starting point for proinflammatory signals in fatty liver disease. Hepatology, 51: 714-715.
9. Fuchs, M. (2012). Non-alcoholic fatty liver disease: The bile acid-activated farnesoid x receptor as an emerging treatment target. J. Lipids, 2012: 934396.
10. Ge, H. Y., Chen, B., Liu, H. L., and Li, H. Q. (2011). Protective effect of Bupleurum Saikosaponin on alcoholic liver disease in rats. Chin J Gerontol., 31: 662-663.2.
11. Hamelet J., Noll C., Ripoll C., Paul J. L., Janel N., Delabar J. M. (2009). Effect of hyperhomocysteinemia on the protein kinase DYRK1A in liver of mice. Biochem. Biophys. Res. Commun., 378: 673–677.
12. Ji, G. Y., Yang, Q. H., Hao, J., Guo, L. N., Chen, X., Hu, J. P., Leng, L., and Jiang, Z. Q. (2011). Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms. Int. Immunopharmacol., 11: 762-768.3.
13. Jin, M. S., and Lee, J. O. (2008). Structures of the toll-like receptor family and its ligand complexes. Immunity, 29: 182-191.
14. Kleiner, D. E., Brunt, E. M., Natta, M. V., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu,Y. C., Torbenson, M. S., Unalp-Arida, A., Yeh, M., McCullough, A. J., and Sanyal, A. J. (2005). Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology, 6: 1312-1321.
15. Kopec, K. L., and Burns, D. (2011). Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy. Nutr. Clin. Pract., 26: 565-576.
16. Kudo, H., Takahara, T., Yata, Y., Kawai, K., Zhang, W., and Sugiyama, T. (2009). Lipopolysaccharide triggered TNF-α-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model. J. Hepatol., 51: 168-175.
17. Lalor, P. F., Faint, J., Aarbodem, Y., Hubscher, S. G., and Adams, D. H. (2007). The role of cytokines and chemokines in the development of steatohepatitis. Semin. Liver Dis., 27: 173-193.
18. Li, S. Q., Su, Z. H., Peng, J. B., Zou, Z. M., and Yu, C. Y. (2010). In Vitro and in Vivo Antioxidant Effects and the Possible Relationship between the Antidepression Efficacy of Traditional Chinese Medicine Formulation Chaihu Shugan San. Chin J. Nat. Med., 8: 353-361.
19. Li, Y. G., Ji, D. F., Zhong, S., Zheng, X. L., and Shi, L. G. (2011). Protective effect of saponins extracted from Panax japonicus on ethanol-induced hepatic cells L-O2 injury. Chin J. Pharmacol. & Toxicol., 25: 289-295.
20. Li, Z. H., Wang, J., Wang, Y. W., Cai, R. L., Sun, J., Ye, M. G., (2012). Effect of Shenlingbaizhu powder on serum levels of EGF, SOD and MDA in ulcerative colitis rats with syndrome of dampness stagnancy due to spleen deficiency. World Chin J. Dig., 20, 410-413.
21. Liu, X. P., Jia, Y. X., Liu, Q., and Wu, J. J. (2011). Effects of Shenglingbaizhusan decoction on CD44，D62p and CD54 in ulcerative colitis rats with asthenia of spleen. Lishizhen Medicine and Materia Medica Res., 22: 2671-2673.
22. Liu, Y., Zhang, Z., Wang, L., Li, J., Dong, L., Yue, W., Chen, J., Sun, X., Zhong, L., and Sun, D. (2010). TLR4 monoclonal antibody blockade suppresses dextran-sulfate-sodium-induced colitis in mice. J. Gastroenterol. Hepatol., 25: 209-214.
23. Liu, Y. L., and Lv, J. H. (2012). Hypolipidemic and antioxidative effect and hepatic protective effect of total glucosides of peony's on non-alcoholic fatty liver. J. Hainan Medical College 18: 158-161.
24. Luo, H. Y., Wang, Y. F., Zhai, S. S., Zhang, Y. J., Nan, X., Bai, C. X., Shi, S. S., Yu, C. Z., Yue, W., Kong, W., Pei, X. T. (2008). The function identification of hepatocyte differentiated from CTLA4-Gene modified bone marrow mesenchymal stem cells. Progress in biochemist and biophysics., 35: 1021-1030.
25. Pang, F. M., Zhang, D. X., and Huang, J. R. (2009). Effect of Chaihu Shugan San on B ultrasonic and the index of liver fibrosis in nonalcoholic fatty liver disease patient. Sichuan J. Tradit. Chin. Med., 27: 66-67.
26. Takeda K., and Akira S. (2004). TLR signaling pathways. Semin. Immunol., 16: 3-9.
27. Tian, J., Wang, Y., He, Z., Gao, Y., Rundhaug, J. E., and Wang, X. (2011). Hydroxyethyl starch (130 kD) inhibits toll-like receptor 4 signaling pathways in rat lungs challenged with lipopolysaccharide. Anesth. Analg., 113: 112-119.
28. Tilg, H., Diehl, and A. M. (2000). Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J. Med., 343: 1467-1476.
29. Tilg, H. and Moschen, A. R. (2010). Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis. Hepatology, 52: 1836-1846.
30. Vanni, E., Bugianesi, E., Kotronen, A., De, M. S., Yki-Järvinen, H., and Svegliati-Baroni, G. (2010). From the metabolic syndrome to NAFLD or vice versa? Dig. Liver Dis., 42: 320-330.
31. Wagner, E. F., and Nebreda, A. R. (2009). Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer, 9: 537-549.
32. Wang, C. H., Geng, Q. G., and Wang, Y. X. (2012). Protective effect of atractylenolide Ⅰ on immunological liver injury. J. Chinese Materia Medica, 37: 1809-1812.
33. Xu, B., Zhang, Y. T., Xu, X. G., Wang, D. J., Xu, T. D., and Li, D. Y (2010). Role of Toll-like receptor 4/MAPKs pathway on monocyte chemoattractant protein-1 secretion induced by oxidized low density lipoprotein in vascular smooth muscle cells. Chin J. Pathophysiol., 26: 848-852.
34. Xue, C. R., Zhou, and X. L. (2010). Glycometabolism in chronic pancreatitis and intervening effect of Chaihu Shugan San. Chin J. Surg. Integr. Tradit. Western Med., 16: 189-191.
35. Yang, Q. H., Hu, S. P., Zhang, Y. P., Xie, W. N., Li, N., Ji, G. Y., Qiao, N. L., Lin, X. F., Chen, T. Y., and Liu, H. T. (2011). Effects of berberine on expressions of uncoupling protein-2 mRNA and protein in hepatic tissue of non-alcoholic fatty liver disease in rats. Chin J. Integr. Med., 17: 205-211.
36. Yimin, Furumaki, H., Matsuoka, S., Sakurai, T., Kohanawa, M., Zhao, S., Kuge, Y., Tamaki, N., and Chiba, H. (2012). A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein. Lab. Invest., 92: 265-281.
37. You, Y., Liu, Y. H., and Gao, S. L. (2012). Effect and mechanism of Shenling Baizhu San on the murine model of inflammatory bowel disease induced by dextran sodium sulfate in mice. Chin J. Exp. Tradit. Med. Form., 18: 136-140.
38. Zeng, J., Li, F., Jia, X. M., and Li, C. Y. (2011). Comparison of the effects of Ginsenoside Rg3 and IFN-alpha on hepatic fibrosis induced by schistosomiasis japonica in mice. J Pathog. Biol., 6: 825-827.
39. Zhang, J., Liu, X. N., Zhang, P. J., Su, H., Lang, J., Zhuang, Z. N., Meng, Z. L., and Wu, X.Y. (2011). Effect of atractylodes macrocephalaon polysaccharide pre-disposal treatment after ischemia reperfusion injury of liver on the chondriosome structure of hepatic cell in rats. J. Hepatopancreatobiliary Surg., 23: 4-6.
40. Zhao, R. X., Zheng, L. Y., Pan, J. Q., Chen, Y. Y., Lv, J. H., Zhou, Y. B., Pan, W. S., and Xiao, Y. (2012). The antioxidative mechanism of total glucosides of paeony on protection against the fatty liver in NAFLD rats. J. Guangdong Pharmaceutical University 28: 430-434.
41. Zheng, C. W., Ding, H. M., Chen, Y., and Feng, Y. B. (2011). Experimental study of saikosaponin on hepatic fibrosis in rats. J Emerg. Tradit. Chin. Med., 20: 755.
42. Zhou, W., Hu, Y., Zhang, H. W., Shen, X. Y., Huang, Y. L., Tang, Z. J., and Hou, A. J. (2009). Effect of carboxymethylpachymaran on signal-transduction of TGF beta-Smad on hepatic fibrosis in rats. Chin J. EthoMed. Ethnopharm., 20: 16-18.